AgroPages-ICL completes the sale of its 50% share of IDE Technologies-Agricultural news

ICL announced that it has completed the sale of its 50% share of IDE Technologies, a desalination and water treatment company. The net proceeds received, after adjustments, amount to approximately $167 million. ICL expects to record a capital gain of approximately $40 million from the sale in the fourth quarter of 2017. The purchaser of ICL's share is a limited partnership whose limited partners include institutional bodies from the Clal Insurance Company Ltd., the Israel Teachers' Union educational funds' group and Ayalon Insurance Company and whose general partner is controlled by Avshalom Felber, IDE's CEO.

A global leader in water treatment solutions, IDE specializes in the development, engineering, construction and operation of enhanced desalination and industrial water treatment plants. The water treatment company was a non-core business of ICL, and its divestment is part of ICL's strategy to divest businesses with low synergy to the company's main mineral chains and to grow ICL's specialty businesses while carefully managing its capital allocation.

ICL's Acting CEO, Mr. Asher Grinbaum, stated, "The completion of our sale of IDE is concurrent with a number of important developments from the past several days including the signing of an agreement with Energian Oil and Gas S.A. for the supply of natural gas at an attractive price, and the sale of low synergy assets for approximately $1 billion. These actions demonstrate our commitment to execute our strategy and strengthen our operational and financial performance and will enable us to promote innovation and growth in ICL's specialty businesses and in precision agriculture, improve our competitive position in commodities, and reduce our debt leverage."

ICL's Executive Chairman, Mr. Johanan Locker, concluded: "ICL is successfully implementing the Board of Directors' decision to divest non-core assets. These steps will enable us to focus on innovation, growth and the creation of a competitive advantage in ICL's fertilizers and specialty solutions businesses."

Subscribe Email:		*
Name:
Mobile Number:

A Deep exploration into Regulatory Analysis, Join upcoming <2024 CROs & CRAOs Manual>Magazine

Join 2024 Formulation & Adjuvant Technology Magazine to Show Your Insights and Innovation SolutionsMagazine

BioEx 2024 successfully held: Biological innovation leading the way towards sustainable agricultureEvent

ICL completes the sale of its 50% share of IDE Technologies

ICL (Israel Chemicals Ltd.)
Israel
Follow

More from AgroNewsChange

Magazine

Hot Topic More

NEWSLETTER